TransEnterix intends to raise $50 million from public sale of stock

Stifel and RBC will be the bookrunners, Raymond James and BTIG assist

By Devika Patel

Knoxville, Tenn., June 8 – TransEnterix, Inc. plans to price a $50 million public offering of common stock with a 30-day greenshoe, according to a preliminary prospectus supplement and an 8-K filed Monday with the Securities and Exchange Commission.

Stifel and RBC Capital Markets are the joint bookrunning managers; Raymond James and BTIG are the co-managers.

Proceeds will be used for research and development, sales, marketing and commercialization related to the SurgiBot System, working capital and other general corporate purposes.

The medical device company is based in Morrisville, N.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.